aod9604 dosing frequency subcutaneous injection MOTS-c Dosage: Protocols & Timing AOD-9604 Peptide Therapy - Wellness,
Description
It is not FDA-approved for anything and has no completed human clinical trials every effect below is preclinical (rodent/cell) only
These figures come from preclinical and pharmacokinetic literature, not from approved human dosing and note the standard route for this molecule is oral
Research context, not medical advice
Standard reconstitution for AOD-9604 AOD-9604 typically arrives as lyophilized (freeze-dried) powder in sealed vials, most commonly in 2mg or 5mg quantities
